Epoch operates a high-throughput CRISPR library and computational pipeline to systematically screen cancer cell lines and patient samples, identifying genetic vulnerabilities for targeted immunotherapy development. The Melbourne startup is based near Monash's Clayton campus and has two oncology partnerships in place. They provide screening-as-a-service to external biotech teams.